tiprankstipranks
Trending News
More News >
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market

Contineum Therapeutics, Inc. Class A (CTNM) Revenue

Compare
206 Followers

Contineum Therapeutics, Inc. Class A Revenue

Contineum Therapeutics, Inc. Class A had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Contineum Therapeutics, Inc. Class A had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
41
Market Cap
$306.67M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
-50.00M
Dec 31, 2023
50.00M-5,000,000,000.00%
Dec 31, 2022
Dec 31, 2021